787 GROWTH HORMONE-RELEASING HORMONE ANTAGONIST INHIBITS GROWTH OF PC-3 HUMAN PROSTATE CANCER BY INACTIVATION OF ERK AND AKT

Authors :: Stefan Buchholz
Marta Zarandi
Andrew V. Schally
Florian Hohla
Ferenc G. Rick
Luca Szalontay
Norman L. Block
Stephan Seitz
Source :: Journal of Urology. 187
Publication Year :: 2012
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2012.

Subjects :: MAPK/ERK pathway
business.industry
Urology
medicine
Cancer research
Antagonist
Cancer
medicine.disease
Growth hormone–releasing hormone
business
Protein kinase B
Human prostate

Full Text Access

Tools